Ortho Clinical Diagnostics Holdings plc, established in 1939 and based in Raritan, New Jersey, operates as a global provider of in-vitro diagnostic solutions. The company caters to both clinical laboratories and the transfusion medicine community, offering a comprehensive range of automated instruments together with the assays, reagents, and consumables required to produce test results. Their product portfolio includes clinical chemistry and immunoassay systems designed to detect and track disease progression across various therapeutic conditions, notably featuring tests for COVID-19 antibodies and antigens.